Your browser doesn't support javascript.
loading
Response to "Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence".
Schoonbeek, Rosanne C; de Jel, Dominique V C; van Dijk, Boukje A C; Willems, Stefan M; Bloemena, Elisabeth; Hoebers, Frank J P; van Meerten, Esther; Verbist, Berit M; Smeele, Ludi E; Halmos, György B; Merkx, Matthias A W; Siesling, Sabine; De Bree, Remco; Takes, Robert P.
Afiliação
  • Schoonbeek RC; University of Groningen, University Medical Center Groningen, Department of Otorhinolaryngology and Head and Neck Surgery, Groningen, The Netherlands. Electronic address: r.c.schoonbeek@umcg.nl.
  • de Jel DVC; Dutch Institute for Clinical Auditing, Scientific Bureau, Leiden, The Netherlands; Netherlands Cancer Institute/Antoni van Leeuwenhoek, Department of Head and Neck Oncology and Surgery, Amsterdam, The Netherlands.
  • van Dijk BAC; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research, Utrecht, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands.
  • Willems SM; University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, The Netherlands.
  • Bloemena E; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Pathology, Amsterdam, The Netherlands.
  • Hoebers FJP; Maastricht University Medical Centre Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht, The Netherlands.
  • van Meerten E; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, The Netherlands.
  • Verbist BM; Leiden University Medical Center, Department of Radiology, Leiden, The Netherlands.
  • Smeele LE; Netherlands Cancer Institute/Antoni van Leeuwenhoek, Department of Head and Neck Oncology and Surgery, Amsterdam, The Netherlands; Amsterdam University Medical Center, University of Amsterdam, Department of Oral and Maxillofacial Surgery, Amsterdam, The Netherlands.
  • Halmos GB; University of Groningen, University Medical Center Groningen, Department of Otorhinolaryngology and Head and Neck Surgery, Groningen, The Netherlands.
  • Merkx MAW; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research, Utrecht, The Netherlands; Radboud University Medical Center, Department of Oral and Maxillofacial Surgery, Nijmegen, The Netherlands.
  • Siesling S; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research, Utrecht, The Netherlands; University of Twente, Department of Health Technology and Services Research, Technical Medical Centre, Enschede, The Netherlands.
  • De Bree R; University Medical Center Utrecht, Department of Head and Neck Surgical Oncology, Utrecht, The Netherlands.
  • Takes RP; Radboud University Medical Center, Department of Otolaryngology/Head and Neck Surgery, Nijmegen, The Netherlands.
Radiother Oncol ; 169: 146-147, 2022 04.
Article em En | MEDLINE | ID: mdl-35101464
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article